Munafa Stock Market Course + Intraday & FNO calls 
Supernus Pharmaceuticals (SUPN) Technical (Analysis) Reports Supernus Pharmaceuticals ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Supernus Pharmaceuticals (SUPN)
Technical Analysis Report for NASDAQ stock SUPN Supernus Pharmaceuticals. Dated: 04 May 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in NASDAQ stock exchange
If you are looking for Tomorrow's Movement Predictions for NASDAQ stock SUPN Supernus Pharmaceuticals then click here. or read Experts views on Supernus Pharmaceuticals or Forecast & share price targets of Supernus Pharmaceuticals
Supernus Pharmaceuticals Opened at 47.53 and Closed at: 48.63, which is 1.6% of previous session's close. It moved within a range of 47.34 and 49.01
The session was a Bullish session with an average volume of 1391900, which is 55.3% of previous session's volumes.
- Even though the stock has shown an up move, but the short term trend of the stock remains negative and in a downtrend.
- Even though the stock has shown an up move, but the mid term trend of the stock remains negative and in a downtrend.
- The stock has shown an up move, and its long term trend is also positive and in an uptrend.
A Dead cross was found 9 days back on short term averages
Support for tomorrow is 47.99 and resistance for tomorrow is 49.66
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 47.64, 46.66 resistance for tomorrow's hourly charts is 49.31, 50
10 Day SMA for Supernus Pharmaceuticals (SUPN) is 49.07 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Supernus Pharmaceuticals (SUPN) is 49.87 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Supernus Pharmaceuticals (SUPN) is 51.08 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 50.46 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Supernus Pharmaceuticals is 47.81 and stock is trading above these levels. This is a good sign for its long term trend
20 DMA of Supernus Pharmaceuticals is at 49.87 and 200 DMA is at 47.81, while 50 DMA and 100 DMA are at 51.08 and 50.46 respectively
Supernus Pharmaceuticals (SUPN) moving average of 20 SMA is at 49.87 and 20 EMA is at 49.55
| Date | Closing Price | 20 SMA | 20 EMA |
| 04 Mon May | 48.63 | 49.87 | 49.55 |
| 01 Fri May | 47.85 | 49.96 | 49.65 |
| 30 Thu Apr | 48.00 | 50.09 | 49.84 |
| 29 Wed Apr | 48.55 | 50.27 | 50.03 |
| 28 Tue Apr | 48.69 | 50.42 | 50.19 |
| 27 Mon Apr | 49.46 | 50.46 | 50.35 |
Supernus Pharmaceuticals (SUPN) moving average of 50 SMA is at 51.08 and 50 EMA is at 50.19
| Date | Closing Price | 50 SMA | 50 EMA |
| 04 Mon May | 48.63 | 51.08 | 50.19 |
| 01 Fri May | 47.85 | 51.13 | 50.25 |
| 30 Thu Apr | 48.00 | 51.18 | 50.35 |
| 29 Wed Apr | 48.55 | 51.25 | 50.45 |
| 28 Tue Apr | 48.69 | 51.3 | 50.53 |
| 27 Mon Apr | 49.46 | 51.34 | 50.6 |
Supernus Pharmaceuticals (SUPN) moving average of 100 SMA is at 50.46 and 100 EMA is at 49.71
| Date | Closing Price | 100 SMA | 100 EMA |
| 04 Mon May | 48.63 | 50.46 | 49.71 |
| 01 Fri May | 47.85 | 50.44 | 49.73 |
| 30 Thu Apr | 48.00 | 50.42 | 49.77 |
| 29 Wed Apr | 48.55 | 50.39 | 49.81 |
| 28 Tue Apr | 48.69 | 50.35 | 49.84 |
| 27 Mon Apr | 49.46 | 50.31 | 49.86 |
Supernus Pharmaceuticals (SUPN) moving average of 200 SMA is at 47.81 and 200 EMA is at 47.23
| Date | Closing Price | 200 SMA | 200 EMA |
| 04 Mon May | 48.63 | 47.81 | 47.23 |
| 01 Fri May | 47.85 | 47.73 | 47.22 |
| 30 Thu Apr | 48.00 | 47.66 | 47.21 |
| 29 Wed Apr | 48.55 | 47.59 | 47.2 |
| 28 Tue Apr | 48.69 | 47.52 | 47.19 |
| 27 Mon Apr | 49.46 | 47.44 | 47.17 |
Voyager Therapeutics has performed better than Supernus Pharmaceuticals in short term. You could have earned much better returns by investing in Voyager Therapeutics, about 2.55% more returns!
Trupanion Inc has performed better than Supernus Pharmaceuticals in short term. You could have earned much better returns by investing in Trupanion Inc, about 8.06% more returns!
Tandem Diabetes has performed better than Supernus Pharmaceuticals in short term. You could have earned much better returns by investing in Tandem Diabetes, about 13.27% more returns!
Si Bone has performed better than Supernus Pharmaceuticals in short term. You could have earned much better returns by investing in Si Bone, about 5.94% more returns!
Supernus Pharmaceuticals has performed better than Quidel Corporation in short term. Holding Supernus Pharmaceuticals could be a better choice for now!
Pro Dex has performed better than Supernus Pharmaceuticals in short term. You could have earned much better returns by investing in Pro Dex, about 7.48% more returns!
Supernus Pharmaceuticals has performed better than Merit Medical in short term. Holding Supernus Pharmaceuticals could be a better choice for now!
Supernus Pharmaceuticals has performed better than Medpace Holdings in short term. Holding Supernus Pharmaceuticals could be a better choice for now!
Supernus Pharmaceuticals has performed better than Luminex Corporation in short term. Holding Supernus Pharmaceuticals could be a better choice for now!
Align Technology has performed better than Supernus Pharmaceuticals in short term. You could have earned much better returns by investing in Align Technology, about 7.57% more returns!
Alkermes Plc has performed better than Supernus Pharmaceuticals in short term. You could have earned much better returns by investing in Alkermes Plc, about 8.05% more returns!
Supernus Pharmaceuticals has performed better than Alnylam Pharmaceuticals in short term. Holding Supernus Pharmaceuticals could be a better choice for now!
Ascendis Pharma has performed better than Supernus Pharmaceuticals in short term. You could have earned much better returns by investing in Ascendis Pharma, about 8.3% more returns!
Supernus Pharmaceuticals has performed better than Catalyst Biosciences in short term. Holding Supernus Pharmaceuticals could be a better choice for now!
Crispr Therapeutics has performed better than Supernus Pharmaceuticals in short term. You could have earned much better returns by investing in Crispr Therapeutics, about 12.38% more returns!
Halozyme Therapeutics has performed better than Supernus Pharmaceuticals in short term. You could have earned much better returns by investing in Halozyme Therapeutics, about 6.13% more returns!
Harrow Health has performed better than Supernus Pharmaceuticals in short term. You could have earned much better returns by investing in Harrow Health, about 18.03% more returns!
Henry Schein has performed better than Supernus Pharmaceuticals in short term. You could have earned much better returns by investing in Henry Schein, about 2.09% more returns!
Supernus Pharmaceuticals Technical analysis of indicators
Price action analysis of Supernus Pharmaceuticals (SUPN) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Supernus Pharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Supernus Pharmaceuticals in short term and the sell signal is strong.
Supernus Pharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Supernus Pharmaceuticals in short term but BUY signal is weak.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Supernus Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 48.87 and Supernus Pharmaceuticals SUPN stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Supernus Pharmaceuticals SUPN stock. Volume based technical analysis of Supernus Pharmaceuticals SUPN stock is negative.
Supernus Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for NASDAQ stock SUPN Supernus Pharmaceuticals These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And SUPN Experts View which covers a lot of information including buying and selling signals
SUPN future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Supernus Pharmaceuticals or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Supernus Pharmaceuticals (SUPN) Technical (Analysis) Reports Supernus Pharmaceuticals ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts
Hindi Video Most Important Stock Market Video. No Success Without This Formula
- NASDAQ Screeners
- NASDAQ Daily Screener
- NASDAQ Weekly Screener
- NASDAQ Monthly Screener
- Support & Resistance
- NASDAQ Shares Near Support
- NASDAQ Shares Near Resistance
